Treatment(s) now being considered-Surgical excision Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Surgical excision Posts on Medivizor

Evaluating the outcomes of current therapies after surgery for patients with stage III melanoma who did not undergo complete lymph node dissection.

Evaluating the outcomes of current therapies after surgery for patients with stage III melanoma who did not undergo complete lymph node dissection.

Posted by on Oct 31, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated the outcomes of immune and molecular targeted therapies after surgery for patients with stage III melanoma who did not undergo complete lymph node dissection. The data showed that the immune and targeted therapies after surgery were associated with increased survival without metastasis among these patients. Some...

Read More

Safety and effectiveness of different therapies after surgery for patients with resected melanoma.

Safety and effectiveness of different therapies after surgery for patients with resected melanoma.

Posted by on Jan 31, 2021 in Melanoma | 0 comments

In a nutshell This study compared how safe and effective are different therapies after surgery in patients with melanoma. This study showed that nivolumab had the best outcome for patients with melanoma following surgery. Some background Melanoma is a type of skin cancer. First line therapy for melanoma involves surgery to...

Read More

Searching for patients with high-risk melanoma to test pembrolizumab before and after surgery

Posted by on Feb 26, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to test the effectiveness of pembrolizumab (Keytruda) before and after surgery in patients with high-risk melanoma. The main outcome that will be measured will be survival without cancer-related events. The details Pembrolizumab is an anti-cancer medication that targets the immune system. It helps the immune system...

Read More

Optimal surgery margins in stage 2 melanomas

Posted by on Nov 14, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the safe margin (the tissue removed around the tumor during surgery) for stage 2 melanomas (tumors with 1-2 mm in thickness). Researchers suggested that the safe margin during melanoma surgery is between 8 and 16 mm.  Some background The standard treatment for patients with stage 2 melanomas (tumor...

Read More

Long-term follow up and survival after melanoma relapse

Posted by on Jul 12, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the factors that predict the return of melanoma (recurrence) and the survival of recurrent melanoma patients following a negative diagnostic report.  Some background One of the most important factors that predict the possibility of melanoma recurrence is the status of sentinel lymph node (SLN). SLN is...

Read More

Surgery as a single or combination treatment in skin cancer

Posted by on Apr 8, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to determine the differences between surgery alone or in combination with biopsy in treating skin cancer.  Some background Sentinel-node biopsy (removes tissue from the lymph node (site that holds immune cells) to determine cancer progression) is the standard-of-care in skin cancer. Wide local excision is a...

Read More